Edition:
United Kingdom

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

36.48USD
13 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$36.48
Open
$36.66
Day's High
$38.38
Day's Low
$36.28
Volume
355,219
Avg. Vol
273,734
52-wk High
$73.90
52-wk Low
$16.71

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.56 -1.070
Jun '18 1.09 -0.819
Mar '18 1.36 -0.617
FY 2017 Dec '17 32.33 0.159
Sep '17 2.39 -0.616
Jun '17 3.58 -0.559
Mar '17 2.70 -0.541
FY 2016 Dec '16 2.34 1.395
Sep '16 1.55 -0.369
Jun '16 0.80 -0.432
Mar '16 0.48 -0.212
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 7 3.11 11.30 1.00 4.15
Quarter Ending Mar-19 5 2.30 5.00 0.00 --
Year Ending Dec-18 8 6.01 14.30 4.00 13.05
Year Ending Dec-19 8 18.51 91.10 0.00 29.68
Earnings (per share)
Quarter Ending Dec-18 9 -0.76 -0.57 -0.89 -0.93
Quarter Ending Mar-19 5 -0.82 -0.74 -0.90 --
Year Ending Dec-18 9 -3.13 -2.73 -3.41 -3.03
Year Ending Dec-19 9 -3.38 -1.86 -4.63 -3.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.49 33.64
P/E High - Last 5 Yrs. -- 308.81 45.61
P/E Low - Last 5 Yrs. -- 85.16 23.70
Beta -- 0.93 0.88
Price to Sales (TTM) 76.97 121.71 5.95
Price to Book (MRQ) 3.91 14.77 4.89
Price to Tangible Book (MRQ) 3.97 13.90 6.50
Price to Cash Flow (TTM) -- 66.81 22.90
% Owned Institutions 41.85 13.77 2.15

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.51
Dividend Yield - 5 Year Avg -- 0.31 1.52
Dividend 5 Year Growth Rate -- 2.84 5.41
Payout Ratio(TTM) -- 25.52 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 350.57 387.08 8.08
Sales (TTM) vs TTM 1 Yr. Ago 570.49 97.70 5.80
Sales - 5 Yr. Growth Rate -- 29.11 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -29.58 27.93 23.27
EPS (TTM) vs TTM 1 Yr. Ago 93.32 -- --
EPS - 5 Yr. Growth Rate -- 33.15 10.88
Capital Spending - 5 Yr. Growth Rate -- 36.76 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.02 2.27
Current Ratio (MRQ) 17.79 5.29 3.07
LT Debt to Equity (MRQ) 0.00 36.70 13.15
Total Debt to Equity (MRQ) 0.00 38.52 17.74
Interest Coverage (TTM) -5.27 -90.95 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.86
Gross Margin - 5 Yr. Avg. -- 48.29 52.38
EBITD Margin (TTM) -784.99 -- --
EBITD - 5 Yr. Avg -- -554.68 10.90
Operating Margin (TTM) -805.36 -797.48 3.24
Operating Margin - 5 Yr. Avg. -- -575.66 6.22
Pre-Tax Margin (TTM) -396.50 -760.61 4.31
Pre-Tax Margin - 5 Yr. Avg. -- -581.06 6.66
Net Profit Margin (TTM) -406.62 -761.46 0.58
Net Profit Margin - 5 Yr. Avg. -- -583.69 2.90
Effective Tax Rate (TTM) -- 25.03 23.26
Effective Tax Rate - 5 Yr. Avg. -- 19.86 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 109,441 22,793,236 803,317,434
Net Income/Employee (TTM) -445,011 1,402,790 94,479,245
Receivable Turnover (TTM) 2.49 19.90 5.78
Inventory Turnover (TTM) -- 2.68 3.71
Asset Turnover (TTM) 0.03 0.42 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.84 -1.66 10.86
Return on Assets - 5 Yr. Avg. -- 2.77 11.96
Return on Investment (TTM) -16.50 -0.29 14.22
Return on Investment - 5 Yr. Avg. -- 1.51 15.54
Return on Equity (TTM) -56.05 0.40 15.99
Return on Equity - 5 Yr. Avg. -- 1.96 16.82
  1 Year 3 Year 5 Year
Sales % 1,990.69 -- --
EPS (TTM) % -194.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CRISPR Therapeutics AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.99 -0.56 99 58
13 Week 21.54 15.62 99 61
26 Week 0.05 -7.55 99 74
52 Week -- -- -- 45
YTD -4.74 -16.34 81 55
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 44.05%
# of Holders: 223
Total Shares Held: 22,859,205
3 Mo. Net Change: 4,128,131
# New Positions: 25
# Closed Positions: 23
# Increased Positions: 55
# Reduced Positions: 38
# Net Buyers: 17
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.